Visual Acuity after Retinal Gene Therapy for Choroideremia
N Engl J Med
.
2016 May 19;374(20):1996-8.
doi: 10.1056/NEJMc1509501.
Epub 2016 Apr 27.
Authors
Thomas L Edwards
1
,
Jasleen K Jolly
1
,
Markus Groppe
1
,
Alun R Barnard
1
,
Charles L Cottriall
2
,
Tanya Tolmachova
3
,
Graeme C Black
4
,
Andrew R Webster
5
,
Andrew J Lotery
6
,
Graham E Holder
5
,
Kanmin Xue
1
,
Susan M Downes
1
,
Matthew P Simunovic
1
,
Miguel C Seabra
3
,
Robert E MacLaren
7
Affiliations
1
University of Oxford, Oxford, United Kingdom.
2
Oxford Eye Hospital, Oxford, United Kingdom.
3
Imperial College London, London, United Kingdom.
4
University of Manchester, Manchester, United Kingdom.
5
Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
6
University of Southampton, Southampton, United Kingdom.
7
University of Oxford, Oxford, United Kingdom
[email protected]
.
PMID:
27120491
PMCID:
PMC4996318
DOI:
10.1056/NEJMc1509501
No abstract available
Publication types
Case Reports
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cataract / complications
Choroideremia / complications
Choroideremia / therapy*
Genetic Therapy*
Humans
Retina
Visual Acuity*
Grants and funding
WT_/Wellcome Trust/United Kingdom
091984/WT_/Wellcome Trust/United Kingdom
EME/12/66/35/DH_/Department of Health/United Kingdom